GSK secures Japan Orphan Drug status for lung cancer ADC
23 March 2026 - Pharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) declared on Monday that it has received Orphan Drug Designation in Japan for its investigational antibody-drug conjugate, risvutat...
M2 Pharma
via M2 Pharma
Updated 2h ago
Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
One Nation secures historic first lower house seat outside Queensland in South Australia election
Next
Naomi Osaka considering how to balance tennis with motherhood ahead of clay court season
Related Articles
ScienceRising Demand for GLP-1 Medications Highlights Continued Importance of Healthy Lifestyle Choices
Internewscast-2h ago-1 sources
Popular anti-obesity drugs must be paired with healthy habits, experts say
Jonel Aleccia-3h ago-1 sources
ScienceLive Science Today: Earth hits record energy imbalance, Hawaii floods and NASA prepares for Artemis II launch
Ben Turner-3h ago-1 sources